Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary

Gynecol Oncol. 2000 Apr;77(1):203-5. doi: 10.1006/gyno.1999.5653.

Abstract

Elevated levels of alpha-fetoprotein (AFP), a fetal serum protein, usually signal the development of hepatoma or germ cell tumors, including endodermal sinus tumors. We report the case of a 52-year-old woman with an alpha-fetoprotein-producing malignant mixed Müllerian tumor (MMMT) of the ovary. Serum AFP was 5348 ng/ml at diagnosis. Immunohistochemistry confirmed that the carcinomatous component of this biphasic tumor was the seat of AFP production. After three cycles of combination chemotherapy, the patient achieved a complete remission. Serum AFP was strongly correlated with response to treatment. This is the first report of AFP production by a MMMT of the ovary without a yolk sac component.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / biosynthesis*
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Mixed Tumor, Mullerian / drug therapy
  • Mixed Tumor, Mullerian / metabolism*
  • Mixed Tumor, Mullerian / pathology
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • Prognosis
  • Treatment Outcome
  • alpha-Fetoproteins / analysis
  • alpha-Fetoproteins / biosynthesis*

Substances

  • Biomarkers, Tumor
  • alpha-Fetoproteins